Medifast Inc at ICR Conference Transcript
Good day, everyone. I am Steph Wissink, Senior Research Analyst from Jefferies. It's my pleasure today to be hosting the team from Medifast. On your screen next to me, you should see Dan Chard, the Company's CEO; and Jim Maloney, the Company's CFO. Thank you both for joining us today. Hopefully, everybody has caught up with the technology. There was a little bit of a lag but we are hopeful everyone is synced up.
Questions & Answers
So let us get started. I want to run through a number of topics, and we only have about 25 minutes, so we are going to do this pretty rapidly.
But the first question, Dan, is for you, is just to talk about the long-term growth targets of the business. What I love about it is it is symmetrical, 15% top-line growth, 15% operating margin. But give us some sense about how you think about kind of maintaining sustainability of demand and the demand strength you've been seeing with optimizing for that operating margin as well.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |